Virtual R&D Event - Vilobelimab in Hidradenitis Suppurativa
InflaRx will host a virtual R&D event on Thursday, February 3rd, beginning at 8:30 AM EST/2:30 PM CET.
The event will provide insight on the development of vilobelimab in Hidradenitis Suppurativa, including details on the study design and novel endpoint for the Phase III trial in this indication.
After registration, you will receive a dedicated link and dial-in details to easily and quickly access the event. Please note: Questions can only be asked via online participation and with full name registration.